Form 4 for GH Guardant Health, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001977179-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-15 | GH | Chudova Darya | CTO | F - Tax | $85.49 | -5,759 | 64.4K | -8% | -$492.3K |
| D | 2026-03-17 | 2026-03-15 | GH | Chudova Darya | CTO | M - OptEx | $0.00 | +10.7K | 70.1K | +18% | $0 |
| D | 2026-03-17 | 2026-03-15 | GH | Chudova Darya | CTO | M - OptEx | $0.00 | -10.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | F | D | 5,759 | $85.49 | 64,352 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2026-03-15 | M | A | 10,714 | $0.00 | 70,111 | D | — | — | |
| 3 | Derivative | Performance-Based Restricted Stock Units | 2026-03-15 | M | D | 10,714 | $0.00 | 0 | D | $0.00 · — to — | 10,714 Common Stock | (F2) This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. (F3) Not applicable for Restricted Stock Units. |